City
Epaper

IIT Kanpur study finds how cholesterol-lowering drug Niacin works

By IANS | Updated: March 13, 2024 13:20 IST

Kanpur, March 13 Researchers at the Indian Institute of Technology (IIT) Kanpur in a new study detailed how ...

Open in App

Kanpur, March 13 Researchers at the Indian Institute of Technology (IIT) Kanpur in a new study detailed how cholesterol-lowering drugs like Niacin work at a molecular level.

Niacin is known for its ability to raise levels of “good” cholesterol or high-density lipoprotein cholesterol (HDL) in the body while flushing out the “bad” type or low-density lipoprotein cholesterol (LDL). However, it also raises risks of some skin issues.

"Niacin is a commonly prescribed drug to lower bad cholesterol and triglycerides while increasing good cholesterol. However, in many patients, the drug causes side effects such as skin redness and itching, referred to as a flushing response. This leads to patients stopping their treatment with adverse effects on their cholesterol levels,” said Prof. Arun K. Shukla of the Department of Biological Sciences and Bioengineering, IIT Kanpur, in a statement.

To understand the side effects of Niacin, the team deployed the cutting-edge cryogenic-electron microscopy (cryo-EM) technology. Using the technology, they visualised the key receptor molecule -- Hydroxycarboxylic acid receptor 2 (HCA2) -- which Niacin and other related drugs activate.

The HCA2, also known as the niacin receptor or GPR109A, regulates fat-related and artery-clogging processes in the human body.

When the receptor gets activated, it can make the blood vessels widen. This explains why Niacin leads to some patients experiencing a red, flushing skin reaction.

The findings, published in the journal Nature Communications will lead to the development of new drugs to lower cholesterol with fewer side effects.

“The visualisation of the receptor molecule GPR109A's interaction with Niacin at the molecular level lays the groundwork for creating new drugs that maintain efficacy while minimising undesirable reactions. The study results will also help in developing related drugs for cholesterol and drugs for other conditions such as multiple sclerosis,” Prof. Shukla said.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

InternationalPM Modi meets Australian counterpart on sidelines of G20 Leaders' Summit

InternationalWill get along fine with Mamdani: Trump

EntertainmentTelangana Governor Jishnu Dev Varma, Minister Komatireddy Venkat Reddy join Telangana-NE Connect festival

EntertainmentNidhhi Agerwal appears before CID in alleged betting app case

Other SportsFootball: Bayern preparing for Champions League's crunch time

Technology Realted Stories

TechnologyRajasthan Police conference concludes with focus on technology, road safety

TechnologyMinistry will work on practical solutions to build more flexible, globally competitive SEZ framework: Commerce Secretary

TechnologyCommunity participation foundation of early disease detection and surveillance: Dr V K Paul

TechnologyIndia-UAE CEPA offers shared innovation, opportunity for startups: Envoy

TechnologyEarly action on AMR key to ensure infections remain treatable, surgeries stay safe: WHO